Interferon beta-1a in combination with azathioprine and low-dose steroids for relapsing-remitting multiple sclerosis: preliminary clinical and MRI data from a two-year, double-blind, randomized, placebo-controlled study

Abstract

Multiple sclerosis, interferon beta-1a, azathioprine, MRI data